News & Updates
Filter by Specialty:
Ceftolozane/tazobactam safe, effective in complicated UTI
Combination therapy with ceftolozane and tazobactam demonstrates a favourable safety profile in children with complicated urinary tract infection (cUTI) similar to that of meropenem and to the previously reported safety profile in adults with cUTI, a study has shown.
Ceftolozane/tazobactam safe, effective in complicated UTI
30 Mar 2023
Remdesivir cuts mortality in COVID-19 patients requiring no or low-flow oxygen
In a systematic review and individual patient data meta-analysis, the broad-spectrum antiviral agent remdesivir reduced mortality in adult patients hospitalized for COVID-19 who did not require oxygen support or only required low-flow supplementation when the need for oxygen arose.
Remdesivir cuts mortality in COVID-19 patients requiring no or low-flow oxygen
30 Mar 2023
How does gel stent perform vs trabeculectomy in open-angle glaucoma?
In the treatment of patients with open-angle glaucoma (OAG), gel stent is noninferior to trabeculectomy in terms of reducing intraocular pressure (IOP) by at least 20 percent, according to a study. Trabeculectomy helps reduce IOP to a greater extent, whereas gel stent leads to fewer adverse events (AEs).
How does gel stent perform vs trabeculectomy in open-angle glaucoma?
30 Mar 2023
Alternative treatments for rhinitis could be worth a try
Nasal sprays containing a drug-free aqueous gel emulsion or essential oils appear to help relieve symptoms of allergic rhinitis, as shown in two studies presented at AAAAI 2023.
Alternative treatments for rhinitis could be worth a try
29 Mar 2023
Promising treatment options for chronic hives on the horizon
Dupilumab, barzolvolimab, and remibrutinib appear to help reduce disease activity in patients with chronic spontaneous urticaria, according to the results of three studies presented at AAAAI 2023.